2-[(1S,2R,10S,11S,14R,15S,17S)-14,17-dihydroxy-2,15-dimethyl-5-oxotetracyclo[8.7.0.0?,?.0??,??]heptadec-6-en-14-yl]-2-oxoethyl acetate

• ChemBase编号: 108727
• 分子式: C23H32O6
• 平均质量: 404.49658
• 单一同位素质量: 404.21988874
• SMILES: O=C(OCC(=O)[C@@]1(O)CC[C@H]2[C@H]3[C@H]([C@@H](O)C[C@]12C)[C@@]1(C(=CC(=O)CC1)CC3)C)C
• Canonical SMILES: CC(=O)OCC(=O)[C@@]1(O)CC[C@@H]2[C@]1(C)C[C@H](O)[C@H]1[C@H]2CCC2=CC(=O)CC[C@]12C
• InChI: InChI=1S/C23H32O6/c1-13(24)29-12-19(27)23(28)9-7-17-16-5-4-14-10-15(25)6-8-21(14,2)20(16)18(26)11-22(17,23)3/h10,16-18,20,26,28H,4-9,11-12H2,1-3H3/t16-,17-,18-,20+,21-,22-,23-/m0/s1
• InChIKey: ALEXXDVDDISNDU-JZYPGELDSA-N

名称和登记号

名称

• IUPAC标准名: 2-[(1S,2R,10S,11S,14R,15S,17S)-14,17-dihydroxy-2,15-dimethyl-5-oxotetracyclo[8.7.0.0?,?.0??,??]heptadec-6-en-14-yl]-2-oxoethyl acetate; 2-[(1S,2R,10S,11S,14R,15S,17S)-14,17-dihydroxy-2,15-dimethyl-5-oxotetracyclo[8.7.0.0^2,^7.0^1^1,^1^5]heptadec-6-en-14-yl]-2-oxoethyl acetate
• IUPAC传统名: β-hc; 2-[(1S,2R,10S,11S,14R,15S,17S)-14,17-dihydroxy-2,15-dimethyl-5-oxotetracyclo[8.7.0.0^2,^7.0^1^1,^1^5]heptadec-6-en-14-yl]-2-oxoethyl acetate
• 别名: 醋酸氢化可的松; 氢化可的松 乙酸盐; 氢化可的松乙酸酯; 11β,17α,21-三羟基-4-孕烯-3,20-二酮 21-乙酸酯; 17-α-羟基皮质甾酮乙酸酯; 17-羟基皮质甾酮 21-乙酸酯; 21-乙酰氧基-4-孕烯-11β,17α-二醇-3,20-二酮; 4-孕烯-11β,17α,21-三醇-3,20-二酮 21-乙酸酯; 醋酸氢化可的松; HYDROCORTISONE ACETATE; Hydrocortisone acetate salt; Hydrocortisone acetate; 21-Acetoxy-11β,17-dihydroxypregn-4-ene-3,20-dione; Cortisol Acetate; Abbocort; Bambicort; Colifoam; Lanacort; NSC 741; Pabracort; Sigmacort; Velopural; Wycort; Hydrocortisone 21-Acetate; Hydrocortisoni acetas; 11β,17α,21-Trihydroxy-4-pregnene-3,20-dione 21-acetate; 17-α-Hydroxycorticosterone acetate; 17-Hydroxycorticosterone 21-acetate; 21-Acetoxy-4-pregnene-11β,17α-diol-3,20-dione; 4-Pregnene-11β,17α,21-triol-3,20-dione 21-acetate; 2-((8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate; Hydrocortisone 21-acetate

登记号

• CAS号: 50-03-3
• EC号: 200-004-4
• MDL号: MFCD00037714
• Beilstein号: 2066841
• PubChem SID: 24895547; 24895620; 24870046; 162095518; 24878508
• PubChem CID: 5744

理论计算性质

• Acid pKa: 12.61023
• 质子受体: 5
• 质子供体: 2
• LogD (pH = 5.5): 1.7162918
• LogD (pH = 7.4): 1.7162892
• Log P: 1.7162919
• 摩尔折射率: 106.5515 cm^3
• 极化性: 42.130913 Å^3
• 极化表面积: 100.9 Å^2
• 可自由旋转的化学键: 4
• 里宾斯基五规则: true

分子性质

理化性质

• 溶解度: Dioxane; DMSO
• 外观: White to Off-White Solid
• 熔点: 216-218°C; 223 °C (dec.)(lit.)
• 比旋光度: [α]20/D +165±2°, c = 1% in dioxane

安全信息

• 保存条件: Refrigerator
• RTECS编号: GM8960000
• 欧盟危险性物质标志: 有害性(Harmful) (Xn)
• 德国WGK号: 3
• 危险公开号: 63
• 安全公开号: 36/37
• GHS危险品标识: GHS08
• GHS警示词: Warning
• GHS危险声明: H361
• GHS警示性声明: P281
• 个人保护装置: dust mask type N95 (US), Eyeshields, Gloves; Eyeshields, full-face particle respirator type N100 (US), Gloves, respirator cartridge type N100 (US), type P1 (EN143) respirator filter, type P3 (EN 143) respirator cartridges

药理学性质

• 相关基因信息: human ... SERPINA6(866)
• 生物活性机理: ACTH secretion inhibitor; Calcium mobilizer; Gluconeogenesis-promoter; Glycogen deposition inhibitor; Phosphorus mobilizer

产品相关信息

• 纯度: ≥97.0% (HPLC); ≥98% (HPLC); 97%
• 级别: Ph Eur; purum; VETRANAL™, analytical standard
• 包装: vial of 250 mg
• 适用性: meets USP testing specifications
• 生物来源: Adrenocortical steroid
• 应用领域: Local antiinflammatory and antiallergic agent
• 药典: testing & handling conforms to Pharmacopeia
• Empirical Formula (Hill Notation): C23H32O6

详细说明

MP Biomedicals - 05208521

MP Biomedicals Rare Chemical collection

Sigma Aldrich - H5760

包装
Supplied in amber screw-cap vials

Sigma Aldrich - H3035

Application
Hydrocortisone acetate salt is used as a stabilized form of the glucocorticoid in studies on stress and homeostasis.

Sigma Aldrich - 46329

法律信息
VETRANAL 商标 Sigma-Aldrich Co. LLC

Sigma Aldrich - 54102

Application
Hydrocortisone 21-acetate is used as a stabilized form of the glucocorticoid in studies on stress and homeostasis.

Toronto Research Chemicals - H714620

Glucocorticoid.

参考文献

• Middleton, B., et al.: J. Biol. Chem., 256, 4827 (1981)
• Moore, A., et al.: Ann. Clin. Biochem., 22, 435 (1985).
• Aldrich Library of 13C and 1H FT NMR Spectra, 1992, 3, 584C, (nmr)
• Reichstein, T., Helv. Chim. Acta, 1937, 20, 953, (isol)
• v. Euw, J. et al., Helv. Chim. Acta, 1942, 25, 988, (struct)
• Zaffaroni, A. et al., J.A.C.S., 1951, 73, 1390, (biosynth)
• Wendler, N.L. et al., J.A.C.S., 1951, 73, 3818, (synth)
• Heller, E., Z. Naturforsch., B, 1959, 14, 298, (ir)
• Shirasaka, M., Chem. Pharm. Bull., 1961, 9, 152, (synth)
• Saucy, G. et al., Helv. Chim. Acta, 1966, 49, 1529; 1967, 50, 1394, (synth, ir, uv, pmr)
• van der Sijde, D. et al., Rec. Trav. Chim. (J. R. Neth. Chem. Soc.), 1966, 85, 721, (synth)
• Smit, A. et al., Rec. Trav. Chim. (J. R. Neth. Chem. Soc.), 1966, 85, 731, (synth, struct, pmr)
• U.K. Pat., 1968, 1 111 320; CA, 70, 2447
• Bhacca, N.S. et al., J.A.C.S., 1973, 95, 8421, (cmr)
• Haskins, N.J. et al., Biomed. Mass Spectrom., 1974, 1, 423, (ms)
• Fiegel, G., Arzneim.-Forsch., 1975, 25, 560, (use)
• Genard, P., Org. Mass Spectrom., 1979, 12, 396, (pmr)
• Castellano, E.E. et al., Acta Cryst. B, 1980, 36, 3063, (cryst. struct)
• Florey, K., Anal. Profiles Drug Subst., 1983, 12, 277, (rev, synth, pharmacol, anal)
• Negwer, M., Organic-Chemical Drugs and their Synonyms, 6th edn., Akademie-Verlag, 1987, 6346; 6986; 7335
• Minagawa, K. et al., J.C.S. Perkin 1, 1988, 587, (synth)
• Kirk, D.N. et al., J.C.S. Perkin 2, 1990, 1567, (pmr)
• Martindale, The Extra Pharmacopoeia, 30th edn., Pharmaceutical Press, 1993, 734
• Lewis, R.J., Sax's Dangerous Properties of Industrial Materials, 8th edn., Van Nostrand Reinhold, 1992, BAV275; HHR000; CNS750; HHQ800; HHQ825; HHQ850; HHQ875